Bill S.278, the leading cannabis legislation this General Assembly, was voted out of the legislature on Friday, May 29, and will soon be sent to the Governor, who will then have five days to act. The version of Bill S.278 that the Senate passed differs from the version the House passed. Though the Senate version was missing several core reforms, such as funding for community and industry reinvestment and medical program improvements, it also included two direct sales proposals for producers that the House struck in the final hours of the session, preventing the Senate from restoring those absolutely crucial proposals. We felt it was important to provide a clear understanding of exactly what's in the bill, should it become law.
Read MoreOn Thursday, April 23, 2026, acting U.S. Attorney General Blanche's “so-called” Department of Justice issued an Order definitionally bifurcating …
Read MoreThe 2026 General Assembly passed its crossover deadline, with Bill S.278, the leading cannabis legislation, receiving last-minute amendments before moving from the Senate to the House. The Cannabis Control Board's March meeting included updates on the Cannabis Business Development Fund from the Agency of Commerce and Community Development, and it held discussions on various issues, including minor cannabinoids like CBD and CBG in cannabis products. Legislators are also working to re-establish an in-state hemp market amid uncertainty in Washington, D.C.
Read MoreOn Friday, March 27, after almost three months in the Senate chamber, Bill S.278, the leading cannabis legislation this session, passed the Senate and is on its way to the House. The legislation has changed significantly since its introduction in January, and this updated summary reflects the latest version of the bill as passed by the Senate.
Read More